BioNTech falls as mRNA therapy for head and neck cancer fails in mid-stage trial
BioNTech falls as mRNA therapy for head and neck cancer fails in mid-stage trial
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BioNTech falls as mRNA therapy for head and neck cancer fails in mid-stage trial